Cite
Lopez-Bujanda ZA, Obradovic A, Nirschl TR, et al. TGM4: an immunogenic prostate-restricted antigen. J Immunother Cancer. 2021;9(6)doi: 10.1136/jitc-2020-001649.
Lopez-Bujanda, Z. A., Obradovic, A., Nirschl, T. R., Crowley, L., Macedo, R., Papachristodoulou, A., O'Donnell, T., Laserson, U., Zarif, J. C., Reshef, R., Yuan, T., Soni, M. K., Antonarakis, E. S., Haffner, M. C., Larman, H. B., Shen, M. M., Muranski, P., & Drake, C. G. (2021). TGM4: an immunogenic prostate-restricted antigen. Journal for immunotherapy of cancer, 9(6), . https://doi.org/10.1136/jitc-2020-001649
Lopez-Bujanda, Zoila A, et al. "TGM4: an immunogenic prostate-restricted antigen." Journal for immunotherapy of cancer vol. 9,6 (2021). doi: https://doi.org/10.1136/jitc-2020-001649
Lopez-Bujanda ZA, Obradovic A, Nirschl TR, Crowley L, Macedo R, Papachristodoulou A, O'Donnell T, Laserson U, Zarif JC, Reshef R, Yuan T, Soni MK, Antonarakis ES, Haffner MC, Larman HB, Shen MM, Muranski P, Drake CG. TGM4: an immunogenic prostate-restricted antigen. J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2020-001649. PMID: 34193566; PMCID: PMC8246381.
Copy
Download .nbib